Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Antibiotic resistance a growing concern with urinary tract infection

As a result of concerns about antibiotic resistance, doctors in the United States are increasingly prescribing newer, more costly and more powerful antibiotics to treat urinary tract infections, one of the most common illnesses in women.

New research at Oregon State University suggests that the more powerful medications are used more frequently than necessary, and they recommend that doctors and patients discuss the issues involved with antibiotic therapy – and only use the stronger drugs if really neeeded.

Urinary tract infections are some of the most commonly treated infections in outpatient settings, with cystitis being the most common type. Cystitis is usually caused by E. coli bacteria that reside in the gut without causing problems, but sometimes they can cause infection.

The OSU research reports that between 1998 and 2009, about 2 percent of all doctor’s office visits by adult women were for this problem, and antibiotics were prescribed 71 percent of the time.

The problem, experts say, is that overuse of the most powerful drugs, especially quinolone antibiotics, speeds the development of bacterial resistance to these drugs. Antibiotic resistance is a natural evolutionary process by which microbes adapt to the selective pressure of medications. Some survive, and pass on their resistant traits.

These issues have gained global prominence with the dangerous and life-threatening MRSA bacteria, methicillin-resistant Staphylococcus aureus, but experts say resistance is a similar concern in many other bacteria.

“Many people have heard about the issues with MRSA and antibiotic resistance, but they don’t realize that some of our much more common and frequent infections raise the same concerns,” said Jessina McGregor, an OSU assistant professor of pharmacy and expert in development of drug resistance.

Since older, inexpensive and more targeted drugs can work for treating urinary tract infections, they should be considered before the more powerful ones, she said.

“This problem is getting worse, and it’s important that we not use the new and stronger drugs unless they are really needed,” McGregor said. “That’s in everyone’s best interests, both the patient and the community. So people should talk with their doctor about risks and benefits of different treatment options to find the antibiotic best suited for them, even if it is one of the older drugs.”

McGregor recently presented data at the Interscience Conference on Antimicrobial Agents and Chemotherapy, which showed that prescriptions for quinolones rose 10 percent in recent years, while other drugs that may be equally effective in treating cystitis remained unchanged.

“Because of higher levels of antibiotic resistance to older drugs in some regions, some doctors are now starting with what should be their second choice of antibiotic, not the first,” McGregor said. “We need to conserve the effectiveness of all these anti-infective medications as best we can.”

Researchers at OSU are developing tools to help physicians select the most appropriate antibiotic for each individual. Additional information such as detailed history of past medication use, knowledge of local community levels of resistance and better doctor-patient communication can help.

“Cystitis is incredibly common, but that’s part of the reason this is a concern,” McGregor said. “It’s one of the most common reasons that many women see a doctor and are prescribed an antibiotic. And any infection can be serious if we don’t have medications that can help stop it, which is why we need to preserve the effectiveness of all our antibiotics as long as we can.”

About the OSU College of Pharmacy: The College of Pharmacy prepares students of today to be the pharmacy practitioners and pharmaceutical sciences researchers of tomorrow by contributing to improved health, advancing patient care and the discovery and understanding of medicines.

Jessina McGregor | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>